Gabrielle Emanuel
-
They can pose a threat to human health — yeast infections are but one example. Scientists say not enough attention is paid to their ability to develop resistance to medications that treat them.
-
U.S. work combatting HIV/AIDS has saved millions of lives globally. Under the Trump administration, funding has been slow in coming and unpredictable, wreaking havoc on people trying to do the work.
-
It's a major source of revenue for the island. And it's controversial. Now countries are sending Cuban doctors home in response to pressure from the Trump administration.
-
Harerimana Ismail of Uganda is a community health worker who checks on kids with HIV. He lost his salary after the Trump administration's aid cuts but he keeps doing his job.
-
That's how researcher Beatriz Garcia Nice describes the new U.S. stance under the Trump administration to programs addressing gender-based violence.
-
It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's also beneficial because the HIV virus is always evolving.
-
Is it TB or not TB? A new study estimates the number of people told they have tuberculosis when they have a different respiratory ailment — and those who do have TB but aren't accurately diagnosed.
-
This mercury-containing compound, used as a vaccine preservative, is commonly used in lower-income countries — and deemed safe. The U.S. is now demanding that Gavi, the Vaccine Alliance stop using it.
-
In the wake of the U.S. withdrawal from WHO, California is the first state to participate in the agency's disease monitoring network. Are others following?
-
The U.S. is giving $1.6 million to researchers to study how the hepatitis B vaccine affects newborns in Guinea-Bissau. After an outcry, the future of the trial is up in the air.
